Related Experiment Video
Updated: Oct 2, 2025

06:46
Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery
Published on: September 27, 2024
403
The Clinical Characteristics, Risk Classification System, and Web-Based Nomogram for Primary Spinal Ewing Sarcoma: A
Zhangheng Huang1, Yuexin Tong2, Qingquan Kong1
1Department of Orthopedics, Orthopedic Research Institute, West China Hospital, Sichuan University, Chengdu, China.
Global Spine Journal
|February 28, 2022
Summary
This study identified key factors like race, chemotherapy, age, and stage to predict survival in primary spinal Ewing sarcoma (PSES). A new nomogram offers more precise prognosis predictions for PSES patients.
Area of Science:
- Oncology
- Orthopedic Surgery
- Biostatistics
Background:
- Primary spinal Ewing sarcoma (PSES) is a rare and aggressive bone tumor.
- Understanding its clinical characteristics and prognostic factors is crucial for patient management.
- Existing prognostic models for PSES may lack precision and broad applicability.
Purpose of the Study:
- To determine the clinical characteristics of patients diagnosed with primary spinal Ewing sarcoma (PSES).
- To develop and validate a prognostic nomogram for predicting overall survival in PSES patients.
- To establish a novel risk classification system for PSES.
Main Methods:
- Retrospective analysis of 314 PSES patients from the Surveillance, Epidemiology, and End Results (SEER) database (2004-2015).
- Identification of independent prognostic factors using univariate and multivariate Cox regression analyses.
- Construction and validation of a prognostic nomogram using calibration curves, ROC curves, and decision curve analysis.
Main Results:
- Race, chemotherapy, age, and disease stage were identified as independent predictors of overall survival.
- The developed nomogram demonstrated strong discrimination and clinical utility in both training and validation cohorts.
- A new risk classification system effectively stratified PSES patients into two distinct risk groups.
Conclusions:
- This study provides robust statistical evidence on the clinical features and prognostic variables of PSES based on a large population.
- The validated prognostic nomogram offers a more accurate and reliable tool for predicting outcomes in PSES patients.
- The new risk stratification system can aid in personalized treatment strategies and patient counseling for PSES.
Keywords:
Clinical characteristicsnomogramprognosisspinal Ewing sarcomasurveillance, epidemiology, and end results databaseMore Related Videos
Related Concept Videos
Cancer Survival Analysis
473
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
473
Rous Sarcoma Virus (RSV) and Cancer
5.5K
Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
5.5K

